Ontario has taken a pioneering step to accelerate the initiation of clinical trials with a new Universal Agreement for Clinical Trials (UACT) for Ontario. Developed
The Accelerating Clinical Trials (ACT) consortium, through an independent, international review panel, has selected CanReview to set up, initiate, and conduct a pan-Canadian single REB review
Ontario has long been an attractive jurisdiction for conducting high-quality clinical trials. However, we must do more to strengthen our status as a competitive jurisdiction
The Government of Ontario has announced new investments in the province’s thriving life sciences sector, including funding that will strengthen Ontario’s clinical trials environment. Unveiled
During the COVID-19 pandemic, Canada’s clinical trials community was forced to adapt its approach to conducting clinical trials, offering innovative options for decentralized or hybrid
